Status
Conditions
Treatments
About
This is an interventional study to investigate the formation and pharmacokinetics of reactive carbonyl species adducts of dietary polyphenols (soymilk, green tea, and blueberry) in humans after a single dose of dietary flavonoids.
Full description
A crossover design was used. Sixteen healthy volunteers (16 for each study, in total 48) were recruited and asked to avoid the consumption of any soymilk, green tea, and blueberry products starting 1 week before intervention and continuing throughout the entire study for a total of 3 weeks.
On week 2, each of the eight participants received 460 ml of soymilk, green tea, and blueberry in a single dose, and afterward, urine and blood samples at different time points over 24 h and fecal samples at different time points over 48 h were collected. Meanwhile, the other eight participants received breakfast (without any soymilk, green tea, and blueberry) at different time points over 48 h were collected.
On the contrary, on week 3, eight participants who received regular milk or water on week 2 received breakfast only, and eight participants who were used as a control on week 2 received soymilk, green tea, and blueberry. And urine and blood samples at different time points over 24 h, and fecal samples at different time points over 48 h for both groups were collected.
Samples will be analyzed by LC-MS/MS. The Pharmacokinetics of conjugates will be investigated.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age 25-70 years
BMI between 18 and 30
Have no known allergy to soy milk
Be not taking antibiotics for six months
Be not currently taking medication
No taking any prescription drugs
If supplements were taken, flavonoid-enriched supplements (see list below) should be avoided.
Major brands Notes: All flavonoid-enriched supplements should be avoided. Soy Isoflavones/ tea/blueberry Lipo-Flavonoid Citrus Bioflavonoids Complex Super Flavonoids Super Antioxidants Quercetin Supplement Essential-C and flavonoids Milk Thistle Other flavonoids supplements, including but not limited: Luteolin, Rutin, etc
No any drugs or supplements within three weeks of the experiment
Be nonsmoking
Have no alcoholic intoxication
Have no extended exposure to industrial wastes
Exclusion criteria
Disease: gout, heart disease, peripheral vascular disease, degenerative kidney, degenerative liver, diabetes, GI disorders, or endocrine disorders
Cancer patients
Primary purpose
Allocation
Interventional model
Masking
48 participants in 3 patient groups
Loading...
Central trial contact
Shengmin Sang, PhD; Yingdong Zhu, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal